Abstract

Chronic non-cancer pain conditions (CNPC) and Major Depressive Disorder (MDD) often co-occur and presents a substantial economic burden. Treatment-resistant depression (TRD) in adults with CNPC can amplify the economic burden. This study examined the impact of TRD on total and MDD-related healthcare resource utilization (HRU) and costs among patients with CNPC and MDD. The study used a retrospective longitudinal cohort design and employed a claims-based algorithm to identify adults with TRD from a US claims database (January 2007- June 2017). Costs and HRU were measured over a 12-month period after TRD/non-TRD index date. Counterfactual recycled predictions from generalized linear models were used to examine associations between TRD and annual HRU and costs. Post-regression linear decomposition identified differences in patient-level factors between TRD and non-TRD groups that contributed to the excess economic burden of TRD. Of the 21,180 adults with CNPC and MDD (mean age 55 years, 74% females, 33% had ≥3 CNPC), 10.1% were identified as having TRD. TRD patients had significantly higher HRU, translating into higher average total costs ($21,015TRD vs $14,712No TRD) and MDD-related costs ($1,201TRD vs $471No TRD) compared to non-TRD patients (all P <0.001). Prescription drug costs accounted for 37.6% and inpatient services for 30.7% of the excess total healthcare costs among TRD patients. TRD patients had significantly higher number of inpatient visits (IRR = 1.30, 95% CI = 1.14-1.47) and emergency room visits (IRR = 1.21, 95% CI = 1.10-1.34) than non-TRD patients. Overall, 46% of the excess total costs were explained by differences in patient level characteristics such as polypharmacy, number of CNPC, anxiety, sleep, and substance use disorders between the TRD and non-TRD groups. TRD poses a significant direct economic burden among adults with CNPC and MDD. Excess healthcare costs may potentially be reduced by providing timely interventions for several modifiable risk factors.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call